​

Aclaris Therapeutics (ACRS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Aclaris Therapeutics Revenue Highlights

Latest Revenue (Y)

$7.83M

Latest Revenue (Q)

$3.30M

Main Segment (Y)

License and Service

Aclaris Therapeutics Revenue by Period

Aclaris Therapeutics Revenue by Year

DateRevenueChange
2025-12-31$7.83M-58.19%
2024-12-31$18.72M-40.09%
2023-12-31$31.25M5.03%
2022-12-31$29.75M340.05%
2021-12-31$6.76M4.30%
2020-12-31$6.48M53.35%
2019-12-31$4.23M-58.11%
2018-12-31$10.09M499.58%
2017-12-31$1.68M100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31--

Aclaris Therapeutics generated $7.83M in revenue during NA 2025, up -58.19% compared to the previous quarter, and up 120.73% compared to the same period a year ago.

Aclaris Therapeutics Revenue by Quarter

DateRevenueChange
2025-09-30$3.30M85.65%
2025-06-30$1.78M22.13%
2025-03-31$1.46M-84.20%
2024-12-31$9.21M111.94%
2024-09-30$4.35M57.12%
2024-06-30$2.77M15.35%
2024-03-31$2.40M-86.35%
2023-12-31$17.57M89.29%
2023-09-30$9.28M396.63%
2023-06-30$1.87M-26.07%
2023-03-31$2.53M-67.39%
2022-12-31$7.75M-59.23%
2022-09-30$19.02M1144.63%
2022-06-30$1.53M5.16%
2022-03-31$1.45M-3.20%
2021-12-31$1.50M-9.52%
2021-09-30$1.66M-9.05%
2021-06-30$1.82M2.64%
2021-03-31$1.78M12.47%
2020-12-31$1.58M9.04%
2020-09-30$1.45M-29.18%
2020-06-30$2.05M45.42%
2020-03-31$1.41M28.49%
2019-12-31$1.09M11.39%
2019-09-30$983.00K-83.24%
2019-06-30$5.87M16.35%
2019-03-31$5.04M37.39%
2018-12-31$3.67M125.37%
2018-09-30$1.63M-55.71%
2018-06-30$3.68M228.80%
2018-03-31$1.12M11.91%
2017-12-31$999.00K46.05%
2017-09-30$684.00K100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30--

Aclaris Therapeutics generated $3.30M in revenue during Q3 2025, up 85.65% compared to the previous quarter, and up 119.27% compared to the same period a year ago.

Aclaris Therapeutics Revenue Breakdown

Aclaris Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24Dec 23Dec 22Dec 21
License and Service$5.95M$16.18M$28.21M$25.10M-
Contract research$1.87M$2.54M$3.04M$4.39M$5.83M
Other---$257.00K-
Other revenue----$931.00K

Aclaris Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 25: License and Service (76.08%), and Contract research (23.92%).

Quarterly Revenue by Product

Product/ServiceDec 25Sep 25Jun 25Mar 25Dec 24Sep 24Mar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
License and Service$795.00K$2.81M$1.33M$1.01M$10.74M$3.70M$1.74M$25.58M$994.00K$1.64M$6.72M$17.90M--------
Contract research$500.00K$485.00K$442.00K$445.00K$1.24M$645.00K$657.00K$1.27M$875.00K$889.00K$866.00K$1.09M$1.22M$1.22M$1.27M-----
Other----------$165.00K$30.00K--------
Other revenue------------$310.00K$232.00K$227.00K-----
Other Revenue---------------$244.00K$218.00K$242.00K$167.00K$118.00K
Laboratory Research Revenue---------------$1.42M$1.61M$1.53M$1.41M$1.33M

Aclaris Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: License and Service (61.39%), and Contract research (38.61%).

Aclaris Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
OMIOwens & Minor$2.76B$697.26M
NEONeoGenomics$727.33M$187.80M
MDXHMDxHealth$70.19M$19.83M
XGNExagen$66.58M$17.24M
MASS908 Devices$56.20M$14.01M
SENSSenseonics$35.26M$8.10M
ACRSAclaris Therapeutics$7.83M$3.30M
ALLOAllogene Therapeutics$22.00K-
EDITEditas Medicine--
CABACabaletta Bio--
BIOABioAge Labs-$2.05M

ACRS Revenue FAQ

What is Aclaris Therapeutics’s yearly revenue?

Aclaris Therapeutics's yearly revenue for 2025 was $7.83M, representing a decrease of -58.19% compared to 2024. The company's yearly revenue for 2024 was $18.72M, representing a decrease of -40.09% compared to 2023. ACRS's yearly revenue for 2023 was $31.25M, representing an increase of 5.03% compared to 2022.

What is Aclaris Therapeutics’s quarterly revenue?

Aclaris Therapeutics's quarterly revenue for Q3 2025 was $3.3M, a 85.65% increase from the previous quarter (Q2 2025), and a -24.09% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $1.78M, a 22.13% increase from the previous quarter (Q1 2025), and a -35.76% decrease year-over-year (Q2 2024). ACRS's quarterly revenue for Q1 2025 was $1.46M, a -84.20% decrease from the previous quarter (Q4 2024), and a -39.32% decrease year-over-year (Q1 2024).

What is Aclaris Therapeutics’s revenue growth rate?

Aclaris Therapeutics's revenue growth rate for the last 3 years (2023-2025) was -74.96%, and for the last 5 years (2021-2025) was 15.75%.

What are Aclaris Therapeutics’s revenue streams?

Aclaris Therapeutics's revenue streams in c 25 are License and Service, and Contract research. License and Service generated $5.95M in revenue, accounting 76.08% of the company's total revenue, down -63.20% year-over-year. Contract research generated $1.87M in revenue, accounting 23.92% of the company's total revenue, down -26.33% year-over-year.

What is Aclaris Therapeutics’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Aclaris Therapeutics was License and Service. This segment made a revenue of $5.95M, representing 76.08% of the company's total revenue.